Back in 2009, Imprivata was enjoying decent sales of its flagship tech product to banks, financial institutions and healthcare facilities. The Lexington, Mass.-based company's sign-on technology allows professionals to log in and out of multiple-user computer stations with the swipe of a card or fingerprint, without the time-sucking and less-than-secure method of logging in user names and passwords multiple times a day. Sales had increased 8 percent over the previous year, but CEO Omar Hussain thought they could be even better.

Although the DEA Electronic Prescriptions for Controlled Substances (EPCS) ruling came out in 2010 many healthcare organizations are just now, in mid-2012, starting to look at what they need to do to roll it out. Why is that?  Well the ruling was just that, a ruling, many factors had to be in place by EMR/e-Prescribing vendors, pharmacy vendors, Surescripts and providers themselves.

On the eve of the HIMSS18 Conference & Exhibition (March 5-9 in Las Vegas), the U.S. Senate provided the biggest boost yet to the already surging momentum behind electronic prescribing for controlled substances (EPCS).